中國以歐盟國家驅逐外交官為由威脅報復 News

中國以歐盟國家驅逐外交官為由威脅報復

(SeaPRwire) - 來自北京駐立陶宛外交使團的三名工作人員被宣布為不受歡迎的人 中國外交部周一在北京發表聲明,強烈譴責立陶宛驅逐其三名外交官的舉動,並警告將採取「反制措施」。兩國關係因維爾紐斯允許台灣代表團享有外交地位以及指控一艘中國船隻參與破壞波羅的海兩條海底電纜而惡化。 中國外交使團的三名工作人員於週五被宣布為不受歡迎的人,立陶宛外交部聲稱其活動違反了《維也納公約》和立陶宛法律。 北京將此舉描述為「肆意挑釁的行動」,並表示「保留對立陶宛採取反制措施的權利」。 這些外交官被勒令在一週內離開該國。然而,立陶宛外交部沒有說明導致這一決定的原因。 「這一決定是根據相關部門提供的資訊,以及未經認可的人員的地位和活動與《維也納外交關係公約》的規定、國際法其他原則和慣例以及立陶宛法律不相符的情況做出的。」外交部在一份聲明中說。 中國外交部回應稱,維爾紐斯「毫無理由」地要求驅逐其外交官,並指責該國違反了關於台灣問題的「一個中國」原則,以及違反其對中立外交關係的「政治承諾」。 此舉發生在兩國關係因立陶宛2021年允許台灣(北京視為中國不可分割的一部分)在立陶宛設立事實上的大使館而惡化之後。作為回應,北京降低了與維爾紐斯的邦交關係並實施了貿易限制。 「中國呼籲立陶宛立即停止破壞中國的主權和領土完整,停止製造兩國關係困難。」外交部說。 這一事件也發生在有關一艘中國船隻「益鵬三號」與波羅的海兩條電信電纜受損事件有關的指控之中。 這些電纜——一條連接瑞典和立陶宛,另一條連接芬蘭和德國——上個月在瑞典領海被切斷。據信,這艘中國船隻當時在該地區,此後一直停泊在丹麥近海的國際水域。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Military Metals Responds to China’s Export Ban on Critical Minerals ACN Newswire

Military Metals Responds to China’s Export Ban on Critical Minerals

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - December 3, 2024) - Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") a leading North American exploration company focused on critical minerals, acknowledges today's announcement by China banning exports of gallium, germanium, and antimony to the United States. This move underscores the urgent need for Western nations to secure reliable long-term sources of these essential materials.Antimony, a critical component in military applications, energy storage, and advanced manufacturing, is now at the forefront of the global supply chain crisis. China's ban, coupled with existing restrictions that came into effect September 15, 2024, has already sent antimony prices soaring by over 228% this year(1). The Western world faces mounting pressure to address its reliance on China for strategic resources critical to national defense and technological innovation. This ban comes at a time when defense sector inventories are at already concerningly low levels.(2)Military Metals recent antimony mineral project acquisitions in Slovakia, Nova Scotia, and Nevada provide shareholders with a pure antimony play with a diverse portfolio in top jurisdictions."This announcement from China reinforces the importance of Military Metals' mission to secure a sustainable, independent future supply chain for critical minerals," said Scott Eldridge, CEO of Military Metals Corp. "The West can no longer afford to rely on adversarial nations for resources essential to our security and economic stability. We are taking proactive steps to meet this growing demand with future domestic and allied sources of antimony."As geopolitical tensions escalate and the trade war intensifies, Military Metals will continue to prioritize the development of critical mineral resources and work closely with governments and industry partners to ensure the West remains resilient and self-sufficient.About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.comFor enquiries, please call 604-722-5381 or 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release include exploration activities, and assumptions related to the continuation of the global demand for antimony. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. These include, geopolitical developments related to the supply of antimony, the continued use of antimony and availability of alternatives, availability of capital and labour in respect of the properties that are the subjects of this news release, the results of any future exploration activities, which cannot be guaranteed, and such other factors as may impact both and any future activities in respect of the properties.. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward looking statements if circumstances, management's estimates or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.(1)Reuters; China bans export of critical minerals to US as trade tensions escalate; By Amy Lv and Tony Munroe; December 3, 2024(2)Heritage Foundation: commentary/It’s Past Time to Re-Supply Our Munitions-Depleted U.S. Navy by Jim Fein; June 17, 2024To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232325 Copyright 2024 ACN Newswire via SeaPRwire.com.
More
全球保險科技公司 discovermarket 進軍拉丁美洲,率先登陸巴西
“` Finance

全球保險科技公司 discovermarket 進軍拉丁美洲,率先登陸巴西 “`

(SeaPRwire) - 聖保羅,2024年12月3日 -- 全球保險科技領導者及嵌入式保險方案創新者 discovermarket 宣佈正式進軍拉丁美洲市場,首站設立巴西子公司。透過此次拓展,discovermarket 旨在透過將創新的保險方案、技術和專業知識帶入拉丁美洲快速發展的保險科技領域,來改變該地區嵌入式保險的未來。 由於數位通路和連網普及率提升,拉丁美洲保險市場在壽險和非壽險領域都屬於全球成長最快的市場之一。僅巴西的普通保險業預計將以 8.8% 的複合年均增長率增長,從 2028 年的 3073 億雷亞爾(616 億美元)增長到 4307 億雷亞爾(857 億美元),突顯了該市場巨大的潛力。 discovermarket 進軍巴西將能與票務、金融科技、旅遊、電信等領域的信譽品牌建立合作夥伴關係,推出能為其客戶帶來真正價值的嵌入式保險方案。 嵌入式保險能無縫融入數位購買流程,讓品牌可以在購買時提供保障。透過提供比傳統方案更經濟實惠且更容易取得的方案,discovermarket 致力於讓更多巴西民眾都能享有保險保障。 discovermarket 首席執行長兼創辦人 Patrick Bühler 表示:「我們透過巴西進軍拉丁美洲市場,代表 discovermarket 開啟了令人興奮的新篇章,我們正努力實現我們的使命,讓所有人都能以經濟實惠、相關且方便取得的方式獲得保障。透過提供無煩惱的數位優先體驗,我們讓巴西及整個地區的品牌都能提升客戶服務,並透過創新的嵌入式保險產品解決保障缺口。」 discovermarket 成立於 2021 年,目標是消除日常煩惱,創造一個人人皆能透過數位管道輕鬆取得保障的世界。憑藉其屢獲殊榮的 API 嵌入式保險平台,discovermarket 一直以來都在重新定義東南亞的保險科技產業。 關於 discovermarketdiscovermarket 是一家總部位於瑞士和新加坡的全球保險科技公司,自豪地為超過 2 億客戶提供服務。我們在東南亞、歐洲和拉丁美洲均有據點,與來自不同產業的信譽品牌合作,為服務不足的客戶彌合保障缺口,為所有人提供方便取得、經濟實惠且相關的嵌入式保險。我們屢獲殊榮的 API 嵌入式保險平台促進保險公司、經紀人和服務供應商之間的無縫連接,讓他們能夠透過創新的嵌入式保險方案開發新的客戶群。 更多資訊,請瀏覽 。 聯絡方式: Emily Yu +65 83963724本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Burning Rock 公佈 2024 年年度股東大會將於 2024 年 12 月 31 日舉行
“` Finance

Burning Rock 公佈 2024 年年度股東大會將於 2024 年 12 月 31 日舉行 “`

(SeaPRwire) - 中國廣州,2024年12月3日 -- 專注於將次世代測序 (NGS) 技術應用於精準腫瘤學領域的Burning Rock Biotech Limited (納斯達克股票代碼:BNR,以下簡稱「公司」或「Burning Rock」) 今日宣佈,將於2024年12月31日上午10:00(當地時間)在公司上海辦公室(上海市閔行區陳行公路2168號浦江智谷10C棟6樓)舉行年度股東大會(「AGM」)。AGM 的通知和委託書可在公司網站的投資者關係部分找到:https://ir.brbiotech.com。 本次股東大會將就以下提案進行表決: 普通決議案:批准任命 Ernst & Young Hua Ming LLP 為公司截至2024年12月31日止財政年度的審計師,並授權公司董事確定審計師的報酬;普通決議案:將韓雨昇和陸綱重新選為公司董事;以及普通決議案:授權公司每位董事採取任何及所有可能必要的行動以執行上述決議,由該董事自行全權決定。 公司董事會完全支持這些提案,並建議股東和美國存託股份(「ADSs」)持有人投票支持這些提案。 公司董事會已將2024年12月4日(紐約時間)的營業結束時間確定為確定有權收到AGM或其任何延期或推遲通知的股東的記錄日期。截至記錄日期營業結束時持有公司每股面值0.0002美元的A類普通股或B類普通股的記錄持有人有權出席AGM及其任何延期或推遲。截至2024年12月4日(紐約時間)營業結束時持有ADSs的記錄持有人,若希望行使其對相關A類普通股的投票權,必須向ADSs的存託機構花旗銀行(Citibank, N.A.)提交投票指示。 公司董事會完全支持擬議的決議,並建議股東和ADSs持有人投票支持擬議的決議。 公司已向美國證券交易委員會(「SEC」)提交經修訂的20-F表格年度報告,其中包含截至2023年12月31日止年度的完整審計財務報表和審計師報告,可在公司網站https://ir.brbiotech.com和SEC網站http://www.sec.gov上查閱。 關於Burning Rock Burning Rock Biotech Limited (納斯達克股票代碼:BNR) 的使命是通過科學守護生命,專注於將次世代測序 (NGS) 技術應用於精準腫瘤學領域。其業務包括:i) 基於NGS的晚期癌症患者治療選擇測試;以及 ii) 癌症早期檢測,該檢測已從概念驗證研發階段進入臨床驗證階段。 安全港聲明 本新聞稿包含前瞻性陳述。這些陳述構成1934年經修訂的證券交易法第21E節以及1995年美國私人證券訴訟改革法案所定義的「前瞻性」陳述。這些前瞻性陳述可以用諸如「將」、「預期」、「預計」、「未來」、「打算」、「計劃」、「相信」、「估計」、「目標」、「有信心」等術語以及類似陳述來識別。Burning Rock還可能在其提交給SEC的定期報告、其年度股東報告、新聞稿和其他書面材料以及其管理人員、董事或僱員向第三方作出的口頭陳述中作出書面或口頭的前瞻性陳述。非歷史事實的陳述,包括關於Burning Rock的信念和預期的陳述,都是前瞻性陳述。此類陳述基於管理層目前的預期和目前的市場和營運狀況,並與涉及已知或未知風險、不確定性和其他因素的事件相關,所有這些都難以預測,而且其中許多都超出Burning Rock的控制範圍。前瞻性陳述涉及風險、不確定性和其他因素,這些因素可能導致實際結果與任何此類陳述中包含的結果存在重大差異。本新聞稿中提供的所有信息均截至本新聞稿發佈之日,除非適用法律規定,否則Burning Rock不承擔因新信息、未來事件或其他原因更新任何前瞻性陳述的義務。 聯繫方式:IR@brbiotech.com本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Lucas GC Limited獲得一項與人力資源相關的重要人工智能發明專利 Finance

Lucas GC Limited獲得一項與人力資源相關的重要人工智能發明專利

(SeaPRwire) - 紐約,2024年12月2日 -- Lucas GC Limited (NASDAQ: LGCL)(「Lucas」或「公司」),一家以人工智能(「AI」)技術驅動的平台即服務(「PaaS」)公司,其技術已應用於人力資源、保險和財富管理行業,今日宣佈已獲得中國發明的專利「基於人才搜尋的整體招聘系統」。 這是Lucas在2024年獲得的第三項專利,使Lucas持有的專利總數達到19項。 該專利使社交媒體影響者能夠通過匹配基於職位要求以及潛在候選人的個人資料和行為生成的個性化招聘內容來聯繫目標人才。 Lucas 首席執行官 Howard Lee 表示:「社交媒體越來越多地被視為一個專業平台,幫助企業和求職者建立聯繫。這項專利證明了Lucas在人力資源應用中核心AI技術的領先地位,它使用AI和深度學習技術生成相關內容,可以顯著提高職位要求與候選人個人資料匹配的準確性,從而大幅提高招聘流程的效率。」 關於 Lucas GC Limited Lucas GC Limited 擁有19項已獲批的美國和中國專利以及70多項註冊的AI、數據分析和區塊鏈技術軟件版權,是一家AI技術驅動的平台即服務 (PaaS) 公司,平台上有超過702,060名代理商。Lucas 的技術已應用於人力資源、保險和財富管理行業。更多信息,請訪問:https://www.lucasgc.com/。 投資者查詢和媒體聯繫:https://www.lucasgc.com/ir@lucasgc.com電話:818-741-0923本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
日出新能源報告強勁銷售增長,主要來自領先的電動汽車和儲能客戶 Finance

日出新能源報告強勁銷售增長,主要來自領先的電動汽車和儲能客戶

(SeaPRwire) - 中國淄博,2024年12月2日 -- 日出新能源有限公司(「日出」、「公司」、「我們」或「我們的」)(納斯達克股票代碼:EPOW)今日宣佈強勁的銷售增長,突顯其在電動汽車(EV)和儲能領域的影響力不斷擴大。2024年10月,公司銷售量達到3,419噸,與2023年10月相比增長了驚人的449.8%。2024年1月至10月,累計銷售量達到22,476噸,與2023年同期相比增長了131.1%。 訂單激增是由於與行業領先的電池製造商建立了合作夥伴關係,包括: Contemporary Amperex Technology Co., Limited (CATL),全球最大的電動汽車和儲能電池製造商,約佔全球市場份額的40%(資料來源:)。HiTHIUM Energy Storage,一家知名的優質靜態儲能電池生產商(資料來源:)。Pylon Technologies Co., Ltd.,一家儲能領域的先驅,被稱為「中國第一儲能股」(資料來源:)。 「我們對這項顯著的訂單增長感到非常自豪,並預計在2024年的最後兩個月銷售額將進一步增長。這證明了我們產品的優質,以及我們在負極材料行業領先地位。」日出首席執行官胡海平先生表示。「贏得像CATL、HiTHIUM和Pylon Technologies這樣世界級客戶的信任,證明了我們技術的實力以及我們對產品質量的堅定承諾。我們將繼續致力於實現卓越的財務業績,並為股東創造長期價值。」 關於日出新能源有限公司 日出新能源有限公司總部位於中國山東省淄博市,通過其合資企業從事鋰離子電池石墨負極材料的生產和銷售。公司合資企業已在中國貴州省建成一座年產能為50,000噸的生產設施。該工廠使用來自可再生能源的廉價電力,這有助於使日出新能源成為低成本、低環境影響的石墨負極材料生產商。胡海平先生是公司的創始人和首席執行官,從1999年開始就是中國石墨負極行業的主要先驅。公司管理團隊還由擁有多年經驗和在石墨負極行業取得輝煌成就的專家組成。此外,公司還在中國運營一個知識分享平台。更多信息,請訪問公司網站:。 前瞻性聲明 本新聞稿中關於公司未來預期、計劃和前景的某些聲明構成 1995 年《私人證券訴訟改革法案》所定義的前瞻性聲明。前瞻性聲明包括關於計劃、目標、策略、未來事件、預期結果、假設以及任何其他尚未發生的事實陳述。任何提及「可能」、「將」、「想要」、「應該」、「相信」、「預期」、「預計」、「估計」或類似非事實詞語的詞語,均應視為前瞻性聲明。由於各種因素,實際結果可能與歷史結果或這些前瞻性聲明中表達的內容存在重大差異。這些因素包括但不限於:公司的戰略目標、公司的未來計劃、市場需求和用戶對公司產品或服務的接受程度、技術更新、經濟趨勢、公司的聲譽和品牌、行業競爭和投標的影響、相關政策和法規、中國宏觀經濟狀況的起伏、相關國際市場狀況以及公司在美國證券交易委員會網站上發佈的 20-F 表格年度報告中披露的其他相關風險和假設。鑒於上述以及其他相關原因,我們敦促投資者訪問美國證券交易委員會的網站,並考慮可能影響公司未來經營成果的其他因素。除非法律要求,否則公司沒有義務公開修訂這些前瞻性聲明的任何變更。 更多信息,請聯繫: 公司: 投資者關係部門 郵箱: 電話:+86 4009919228本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Kandi Technologies 委任 SC Autosports 新任執行長
“` Finance

Kandi Technologies 委任 SC Autosports 新任執行長 “`

(SeaPRwire) - 浙江金華,中國,2024年12月2日 -- Kandi Technologies Group, Inc. (NASDAQ GS: KNDI)(「Kandi」或「本公司」),一家領先的全電動個人交通工具和多功能車輛生產商,今日宣佈,在其管理團隊經過徹底審查和決策後,俞濱先生已被任命為其美國子公司SC Autosports(營業名稱為Kandi America)的首席執行官(CEO)。此舉是Kandi推進高質量發展計劃的戰略舉措之一。 俞先生是美國公民,擁有超過20年的企業管理經驗,曾在多家領先的跨國公司擔任高級領導職務。他的專長涵蓋整個產品生命週期,從研發到營銷,並包括跨地區管理跨國團隊,包括美國。 在加入Kandi之前,俞先生曾擔任以下關鍵職位: 2020年10月 – 2024年2月:杭州BoulderAI Technologies Co., Ltd.副總裁。2014年10月 – 2019年7月:華為企業網絡(硅谷)首席技術官兼產品管理副總裁。2011年10月 – 2014年10月:華為美國研究院(硅谷)全球營銷解決方案中心高級總監兼首席雲轉型和網絡架構師。2002年6月 – 2011年10月:思科系統亞太區總部香港辦事處邊緣路由和安全產品線首席市場技術和管理專家。1995年4月 – 2001年5月:思科系統(硅谷)邊緣路由器研發高級工程師。 俞先生擁有1992年6月獲得的加利福尼亞大學洛杉磯分校計算機工程碩士學位,以及2011年1月獲得的香港大學工商管理碩士學位。 同時,戴卓爾先生將從SC Autosports首席執行官的職位轉任副總裁,他將專注於擴展公司的經銷商網絡。 Kandi首席執行官陳豐先生評論道:「我們很高興歡迎俞濱先生加入SC Autosports的領導團隊。憑藉其豐富的經驗和卓越的業績,我相信他將通過加強渠道開發和擴大客戶群,根據Kandi新的增長策略,將我們的業務推向新的高度。我們也感謝戴卓爾先生作為首席執行官做出的重大貢獻,並期待他繼續努力建設一個更全面、更強大的經銷商網絡。」 關於Kandi Technologies Group, Inc. Kandi Technologies Group, Inc. (KNDI)總部設在浙江省金華新能源汽車小鎮,從事各種車輛產品的研發、製造和銷售。Kandi的主要業務運營通過其全資子公司浙江堪迪科技集團有限公司(「浙江堪迪科技」)(原浙江堪迪汽車有限公司)及其子公司開展,包括堪迪電動汽車(海南)有限公司和SC Autosports, LLC(營業名稱為Kandi America),即Kandi在美国的全资子公司,及其全资子公司Kandi America Investment, LLC。浙江堪迪科技已成為中國領先的純電動汽車零部件和越野車製造商之一。 安全港聲明 本新聞稿包含某些可能包含「前瞻性陳述」的陳述。本新聞稿中所有非歷史事實的陳述均為「前瞻性陳述」。這些前瞻性陳述通常通過使用「相信」、「預期」或類似表達來識別,其中涉及已知和未知的風險和不確定性。儘管本公司相信這些前瞻性陳述中反映的預期是合理的,但它們確實涉及假設、風險和不確定性,並且這些預期可能會被證明是不正確的。您不應過度依賴這些前瞻性陳述,這些陳述僅在本新聞稿發佈之日有效。由於各種因素,本公司的實際結果可能與這些前瞻性陳述中預期的結果存在重大差異,包括本公司定期向證券交易委員會提交並可在證券交易委員會網站()上獲得的報告中討論的風險因素。所有歸屬於本公司或代表其行事的個人所作的前瞻性陳述均完全由這些風險因素明確限定。除適用證券法規定的情況外,本公司不承擔更新這些前瞻性陳述的義務。 關注我們的Twitter:@ Kandi_Group 聯繫方式: Kandi Technologies Group, Inc.羅可娃女士+1 (212) 551-3610 The Blueshirt Group加里·德沃查克先生,CFA本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More

eBRAM Partners with Agency for Volunteer Service to Launch ‘Pro-Bono Online Mediation Scheme for Water Seepage Disputes’

HONG KONG,Dec 3, 2024 - (ACN Newswire via SeaPRwire.com) - In order to resolve conflicts and disputes between property owners and occupants in Hong Kong caused by water seepage issues, eBRAM International Online Dispute Resolution Centre (“eBRAM”), an independent non-profit arbitration and mediation organisation, today joined hands with the Agency for Volunteer Service to officially launch the Pro-bono Online Mediation Scheme for Water Seepage Disputes (“Scheme”). The Scheme is free of charge and aims to foster a harmonious community by providing the public with efficient and economical online mediation services to help resolve water seepage disputes in the community.The Scheme has received strong support from the “Joint Office” set up by the Food and Environmental Hygiene Department and the Buildings Department. When water seepage issues arise, both parties involved can agree to conduct mediation at any stage. The parties can do so by submitting a request through eBRAM’s platform under the Scheme. The platform will then arrange for independent and neutral volunteer mediators to mediate the parties’ dispute. The Scheme aims to enable parties to resolve disputes in the simplest, most cost-effective, and time-efficient manner.Actively Assumes Social Responsibility and Alleviates the Concerns and Difficulties of the CitizensThe issue of building leakage or water seepage is a common source of dispute in the Hong Kong community, and multi-faceted issue encompasses cost split and responsibility for carrying out repairs . This issue has been troubling property owners and occupants in Hong Kong, as it is complicated and involves multiple parties’ responsibilities. Traditional legal proceedings are time-consuming and expensive, making it difficult to resolve these issues in a short period of time, which often causes great suffering to the residents involved.In view of this, as a leading non-profit arbitration and mediation organisation in Hong Kong, eBRAM actively uses innovative approaches to address social livelihood issues. Launched in cooperation with the Agency for Volunteer Service and supported by the Food and Environmental Hygiene Department and the Buildings Department, this free online mediation service fills a gap in legal services and provides an efficient, economical and convenient solution for members of the public who are in need.Efficiently Resolves Water Seepage Disputes, Highlights Advantages of Online MediationeBRAM’s mediation rules and online dispute resolution platform have overcome the time and space limitations of traditional mediation, allowing parties to participate in mediation process anytime and anywhere. Compared with cumbersome litigation procedures, online mediation is fast and efficient, and lowers the threshold for resolving disputes so that both parties do not have to go through lengthy legal proceedings and pay expensive litigation fees. This flexible service model meets the needs of the busy public living in modern cities to build a harmonious community.In addition, mediation is led by the parties involved, who have more control over the outcome. Both parties can work together to agree on a solution, rather than leaving the decision-making process entirely to the court. At the same time, mediation emphasizes fairness and understanding, which aims to reduce tensions between the parties, avoids escalation of conflicts, and protects their neighbourhood relations. As a third party, professional mediators maintain a neutral stance and assist the parties in discussing feasible solutions that give them peace of mind.Innovative LawTech to Help Build a Harmonious FutureDr Thomas So, JP, Chairman of eBRAM, said, "We are committed to serving our society, promoting sustainable development, and giving back to the community by leveraging innovative technologies and applying our expertise. By collaborating with the Agency for Volunteer Service and with the support of the Food and Environmental Hygiene Department and the Buildings Department, the launch of the free ‘Pro-bono Online Mediation Scheme for Water Seepage Disputes’ has not only helped solve the public’s livelihood issues, but also provided new ideas for building a harmonious and inclusive social environment. Looking ahead, we will continue to work closely with the government and other organisations to provide high-quality and efficient dispute resolution services to more members of the public."Ms. Melissa Pang, BBS, MH, JP, Chairman of the Agency for Volunteer Service, said, "We have always been attentive to the needs of the members of the public and are committed to playing a pivotal role in collaborating with various sectors of society to address livelihood issues. By having dedicated professional mediators who are passionate about serving society as volunteer workers, we provide free mediation services to relevant owners and occupants through eBRAM’s online platform, believing that we can play a crucial role in resolving building leakage disputes within the community. We look forward to promoting community harmony through this innovative initiative, ensuring that members of the public can live and work in peace."According to the figures released by the Joint Office, over the past five years, there have been an average of over 40,000 complaints per year on water seepage issues. The number of cases in which the source of water seepage was identified and relevant investigations completed averaged around 5,800 cases per year, accounting for approximately 14.5% of the total number of complaints. As at September 2023, the number of cases under investigation was around 10,000. Between 2020 and 2022, investigation on approximately 30% of the cases could not be completed and complainants were not informed of the investigation results within 90 working days. The “Pro-bono Online Mediation Scheme for Water Seepage Disputes” initiated by eBRAM and the Agency for Volunteer Service is set to effectively reduce the time required to handle water seepage cases, increase efficiency in addressing the public’s livelihood issues, and play a more active role in promoting harmony in the community and reducing social conflicts.“Pro-bono Online Mediation Scheme for Water Seepage Disputes” Webpage:https://ebram.org/Water_Seepage_POM_Scheme/?language=en Copyright 2024 ACN Newswire via SeaPRwire.com.
More
MHI Thermal Systems Receives “Minister of the Environment Award for Climate Action 2024” JCN Newswire

MHI Thermal Systems Receives “Minister of the Environment Award for Climate Action 2024”

TOKYO, Dec 3, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has received a Minister of the Environment Award for Climate Action 2024 for development of its JHT-Y/JHT-YI series of large-capacity centrifugal chillers adopting the HFO-1234yf refrigerant with a low GWP(1). The award, sponsored by the Japanese Ministry of the Environment, was presented in the Technological Development and Commercialization category. An awards ceremony took place in Tokyo on December 2.The Awards CeremonyThe Minister of the Environment for Climate Action Award program was renewed in 2020 to reflect recent trends in climate change measures and succeeded the Environment Minister's Awards for Global Warming Prevention Activity, which had been held since 1998. The awards are given annually to individuals or groups having made noteworthy contributions to climate change mitigation (measures to curb greenhouse gas emissions) and accommodation to climate change (measures to avert or reduce impacts from climate change). This 2024 award is MHI Thermal Systems' third to date: in 2019, the Company received an Environment Minister's Award for its high-efficiency centrifugal chiller ETI-Z series that adopt a low-GWP refrigerant(2); and in 2021, the Company garnered the award for development and promotion of an air-to-water type heat pump using a low-GWP refrigerant(3).The constant-speed JHT-Y and inverter-equipped JHT-YI are new series for large-capacity centrifugal chillers launched in June 2022. Both models in the series adopt the HFO-1234yf refrigerant with extremely low environmental impact (GWP below 1) and the capacities ranging from 300 to 5,400 refrigeration tons (RT)(4). The JHT-Y and JHT-YI are the first centrifugal chillers with capacities up to 5,400 RT commercially offered in Japan with a low-GWP refrigerant. With a newly designed compressor, outstanding efficiency has been achieved: the constant-speed model to achieve a maximum rated COP(5) of 6.4, the inverter-equipped model achieves an IPLV(6) of 8.8 and a maximum part load COP of 24.9. A smaller compressor size, together with the optimized centrifugal chiller structure layout, also contributes to the effective use of the space, enabling smooth installation from existing equipment. The replacement of an existing equipment using a higher-GWP HFC (hydrofluorocarbon) refrigerant with the JHT-YI can reduce annual energy consumption and CO2emissions by approximately 65%(7), contributing significantly to mitigating environmental impacts. The JHT-Y and JHT-YI models are also adaptable to a wide range of applications: air-conditioning, heating, as well as low-temperature and heating processes in beverage plants, etc.The HFO-1234yf refrigerant, which is also used in car air-conditioners and vending machines, has a GWP of below 1 and ODP(8) of zero, and is categorized as non-Freon refrigerant according to Japan's Revised Fluorocarbons Recovery and Destruction Law(9). For these reasons, it is not subject to this Law that regulates the Fluorocarbons' emissions into the atmosphere, recovery, and destruction after usage. Concerning an equipment with higher-GWP HFC refrigerant including HFC-134a, which was widely used before the revised legislation took effect, it has been made compulsory to reduce in both their production and usage volumes as it has a significant impact on global warming. In 2025 and onward, it is scheduled that the regulations on the supply of equipment with higher-GWP refrigerants to the market will be tightened further in the Japanese market, therefore, currently the demands for the equipment with low-GWP refrigerants, ex. the JHT-Y/JHT-YI series, are increasing and earlier upgrading is required in the market.MHI Thermal Systems is Japan's leading manufacturer of centrifugal chillers, having delivered numerous units for district cooling/heating, factory air-conditioning, etc. Going forward, the Company will continue to focus on developing high-performance products using low-GWP refrigerants covering - together with the small and medium-capacity ETI-Z series - a capacity span of 150 to 5,400 RT, as its way of contributing to environmental protection on a global scale.(1) GWP: global warming potential. CO2 is assigned a GWP of 1. The lower the GWP factor, the less impact on the environment.(2) For further information, refer to the following press release: https://www.mhi.com/news/191203.html(3) For further information, refer to the following press release: https://www.mhi.com/news/21112502.html(4) Capacity above 2,700 RT requires two compressors (parallel type).(5) COP: coefficient of performance as calculated based on Japanese Industrial Standards (JIS). The higher the COP, the higher the level of energy savings.(6) IPLV: integrated part load value, an indicator of the efficiency of an air-conditioner during part load operation. The higher the IPLV, the higher the level of energy savings.(7) Compared with our previous model (20 years ago)(8) ODP: ozone depletion potential, a coefficient expressing the relative amount of degradation to the ozone layer compared to trichlorofluoromethane (CFC-11), a refrigerant previously in wide use which has a fixed ODP of 1.0. The lower the ODP, the lower the destructive impact on the ozone layer.(9) This revised law, which took effect on April 1, 2015, stipulates rules for the rational use and proper management of fluorocarbons.JHT-Y/JHT-YI SeriesAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Fujitsu entrepreneurship program spins out first start-up company JCN Newswire

Fujitsu entrepreneurship program spins out first start-up company

KAWASAKI, Japan, Dec 3, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has spun out blue carbon services company BLUABLE Ltd. from its entrepreneurship program Fujitsu Innovation Circuit (FIC.) The company, established as a startup in October 2024, is the first company to be successfully generated by the program.BLUABLE has secured funding from Spinout Capital Fund No.1, a Japanese venture capital fund for corporate spinouts, in November 2024. The funds will be used to validate the product-market fit of the products and services developed.BLUABLE aims to promote carbon neutrality and contribute to the sustainability of the marine environment by providing services related to blue carbon, i.e., carbon captured and stored in the world's ocean and coastal ecosystems.A significant amount of blue carbon is stored in seaweed, and a rise in seawater temperatures has caused a loss of seaweed beds and damage to seawater quality and conditions.BLUABLE produces kits to encourage seaweed bed growth. The kits are made from a material which seaweed can easily adhere to and no heavy equipment is needed to place the kits in the ocean, saving resources as compared to current cultivation methods. In addition, BLUABLE measures the blue carbon secured through utilization of its kits and uses the data to apply for J Blue Credits (1). Currently, BLUABLE is conducting field trials for seaweed bed cultivation at 16 undersea locations in Japan.The company plans to verify more advanced measuring techniques for blue carbon using IoT and AI.Fujitsu will provide its technology to BLUABLE, including its ocean digital twin (2), as it works toward preserving the world’s marine environment. In addition, through FIC, Fujitsu will continue contributing to a sustainable society by fostering talent and businesses that can take on the challenge of resolving societal issues.About Fujitsu Innovation Circuit (FIC)FIC, launched in November 2021 as part of Fujitsu Transformation, is a program to cultivate human resources with entrepreneurial skills and generate new businesses. FIC is comprised of the Ignition program that seeks to cultivate entrepreneurship, and the Challenge program that encourages employees to create new businesses. Over 2,500 Fujitsu employees around the world are participating in FIC.()) J Blue Credit :System of blue carbon credits issued and managed by the Japan Blue Economy (JBE) Association according to the results of an assessment and certification process implemented by an independent third-party committee.(2) Ocean digital twin :Technology that reproduces the marine environment with high precision in a digital space. Capable of collecting and modelling a wide variety of marine data.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.
More

從亞洲到全球 順豐控股開啟新一輪價值躍升

香港, 2024年12月2日 - (亞太商訊 via SeaPRwire.com) - 在中國物流行業,順豐控股(6936.HK)是當之無愧的領跑者。公司從時效快遞起家,通過直營模式,確立在中高端時效快遞領域的領先地位,並率先進行了資源全球化佈局,進行業務的多元化佈局,逐步發展成為業務覆蓋物流行業各核心細分領域的綜合物流服務龍頭。2023年,順豐控股實現營收人民幣2,584億元,在全球綜合物流服務提供商中僅次於聯合包裹服務公司(UPS)、敦豪(DHL)和聯邦快遞(FedEx)。站在行業變革的關鍵時刻,順豐控股將目光從中國及亞洲擴展至全球市場。11月27日,公司於聯交所上市,以期藉助這一契機,加速全球化戰略的推進,助力公司在高質量發展的基礎上,實現新一輪的躍升。新老業務協同發展 新業務陸續迎來盈利增長順豐控股全方位佈局物流業務,其業務版圖覆蓋時效快遞、經濟快遞、快運、冷運物流、同城即時配送以及供應鏈和國際服務領域,在各業務領域均建立領先競爭力。其中,時效快遞作為順豐控股基本盤,2023年市場份額高達63.9%。過往期間,公司持續夯實時效服務競爭力,同時不斷拓展新興產業客群和新業務場景,營收穩步增長,2024年上半年該項業務營收同比增加5.6%。同時,順豐控股新業務也陸續收獲了耕耘果實。快運業務方面,順豐控股在客戶便利性、時效性、准時性等方面持續打造競爭優勢,大件業務於2022年首次實現轉盈,2023年盈利進一步擴大。同城即時配送分部方面,公司通過業務結構優化、精細化管理及科技驅動提升經營能力,2023年首次實現整體盈利,2024年上半年淨利潤擴大至0.62億元。與此同時,順豐控股還通過采取多项降本增效举措,包括推進多網融通,整合天網、地網的物流資源與信息網、優化業務結構以及精益管理等,提升運營效率,促進降本增效。2024年上半年,公司毛利率達到13.6%,較去年同期提升0.3個百分點。可以預見,隨著新業務規模的持續增長以及降本增效效應的加持,公司的盈利水平有望進一步提升。行業景氣度有望延續 國際化拓展高質量成長可期從行業的角度看,物流行業作為經濟的"晴雨表",依然蘊含著巨大的市場機遇。預計2028年,全球物流支出總額將達到13.8萬億美元,2023年至2028年複合年增長率為4.4%。其中,亞洲作為全球規模最大及增長最快的物流市場,且是集中度最低的地區之一,擁有可觀的增長前景,預計2023年至2028年間複合年增長率為5.5%。順豐控股多年經營,於中國市場打下堅實發展根基,品牌形象深入人心。隨後公司深耕中國及亞洲市場,不斷孵化新產品、投資基礎設施,市場份額持續擴大,為未來全球拓展做好準備。未來,順豐控股計劃鞏固其在中國的市場領導地位,同時擴展在亞洲和全球的影響力。在亞洲市場,依託已經建立的龐大的本地物流網絡、廣泛的互通互聯、強大的品牌知名度及團隊,順豐控股有能力複製中國成功經驗,擴展高增長市場。在亞洲以外,利用公司品牌、成本優勢以及綜合物流能力,順豐控股能夠為全球客戶提供具有價格競爭力的一站式解決方案,佔據更大的市場份額。隨著登陸港股資本市場,打造國際化資本運作平台,順豐控股的綜合競爭力也將在資本的助力下得到加強,為國際化戰略加速推進提供有力支持。疊加持續提升其經營能力,公司高質量可持續增長可期。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More

一邦攜手義務工作發展局推出「滲漏糾紛義務網上調解服務」

香港, 2024年12月3日 - (亞太商訊 via SeaPRwire.com) - 為解決本港業主及住戶因樓宇滲水問題所引發的矛盾和糾紛,獨立非營利仲裁調解機構一邦國際網上仲調中心(「一邦」)攜手義務工作發展局,於今天正式推出費用全免的「滲漏糾紛義務網上調解服務」,致力為市民提供高效、經濟的網上調解服務,協助解決社區滲水糾紛,促進鄰里和諧及實現社區共融。該服務計劃獲得由食物環境衞生署及屋宇署組成的「聯合辦事處」(俗稱「滲水辦」)的大力支持,當滲水問題發生後,有關雙方可以在任何階段隨時同意進行調解, 屆時市民可通過由一邦的網站提交聯絡資料及調解申請書,並透過平台安排獨立及中立的義務調解員進行調解。此免費調解服務務求雙方以最簡單、符合效益及省時的方法解決爭議。積極承擔社會責任,為市民解憂緩困樓宇漏水或滲水問題是香港社區中常見的糾紛來源,當中涉及費用分攤、維修責任等不同層面的問題。此民生問題纏擾大量香港業主及住戶、複雜且涉及多方責任。傳統的法律程序既耗時又昂貴,難以在短時間内解決問題,涉事居民均苦不堪言。有見及此,一邦作為香港領先的非營利仲裁調解機構,積極以創新思維解決社會民生議題。本次與義務工作發展局合作、得到食物環境衞生署及屋宇署支持推出的免費義務網上調解服務,彌補了這一項法律服務空白,為有需要的市民提供了一個高效、經濟、便捷的解決途徑。高效解決滲水糾紛,網上調解優勢顯著一邦的調解規則及網上爭議解決平台突破了傳統調解的時間和空間限制,讓當事人可以隨時隨地參與調解過程,相比繁瑣的訴訟程序,網上調解快捷高效,雙方無需經歷冗長的法律程序及昂貴的訴訟費用,降低解決爭議的門檻。這種靈活的服務模式符合現代都市生活繁忙的市民的需求、構建和諧社區。此外,調解過程由當事人主導,當事人擁有對結果的更多控制權,雙方能共同商定解決方案,而非將決策權完全交予法庭。同時,調解強調公平和理解,能緩解雙方的緊張情緒,避免衝突升級,並在一定程度上保護雙方的鄰里關係。而專業調解員作為第三方,秉持中立態度,協助雙方探討可行的解決方案,讓各方安心。創新法律科技,助力構建和諧未來一邦主席蘇紹聰博士表示:「我們一直以服務社會、推動可持續發展為己任,運用創新科技和專業知識回饋社會。此次能夠與義務工作發展局合作,得到食物環境衞生署及屋宇署支持,推出免費的『滲漏糾紛義務網上調解服務』,不僅解決民生問題,更為建設和諧共融的社會環境提供了新思路。未來,一邦將繼續與政府及其他機構緊密合作,為更多市民提供優質、高效的爭議解決服務。」義務工作發展局主席彭韻僖女士表示:「我們一直關注市民需求,並致力承擔樞紐角色,與社會各界建立夥伴關係以解決民生問題。我們招募配對有心服務社會的專業調解員義工,透過一邦的網上法律平台,向相關業主或租戶提供免費的調解服務,相信能在解決樓宇滲漏爭議發揮關鍵作用。我們期待透過是次創新措施,促進社區和諧,使市民都能安居樂業。」根據「滲水辦」的數字顯示,過去5年平均每年接獲逾4萬宗涉及單位滲漏的投訴,成功找出滲水源頭並完成調查的個案數目,平均每年約有5,800宗,佔整體投訴約14.5%。截至2023年9月,仍在進行調查的個案數目約為1萬宗,而在2020至2022年間約有30%的個案未能於90個工作天內完成調查並告知舉報人調查結果。一邦攜手義務工作發展局推動的「滲漏糾紛義務網上調解服務」,相信能夠有效縮減處理滲水個案的時間,提高效率以解決市民的生活問題,並在促進社區和諧、減少社會矛盾方面發揮更大作用。「滲漏糾紛義務網上調解服務」網頁:https://ebram.org/Water_Seepage_POM_Scheme/?language=tc Copyright 2024 亞太商訊 via SeaPRwire.com.
More
#CTS24 Concluded Last Week, Advancing Net-Zero Goals and Sustainable Solutions ACN Newswire

#CTS24 Concluded Last Week, Advancing Net-Zero Goals and Sustainable Solutions

London, UK, Dec 2, 2024 - (ACN Newswire via SeaPRwire.com) - The 3rd edition of the London Climate Technology Show concluded last week, paving a vital roadmap towards fully decarbonising our planet through sustainable technologies. The event brought together policymakers, eco-technology leaders, industry professionals, and innovators, all unified in their call for an immediate shift to sustainable and green solutions to secure a better future for the planet.The two-day event opened on 27th November with an inspiring keynote by Felicity Burch, Executive Director of the Responsible Technology Adoption Unit at the Department for Science, Innovation, and Technology (DSIT), who spoke about AI Innovation in Clean Energy and the DSIT's Manchester Prize. Following her, Ing. Abigail Cutajar, CEO of the Climate Action Authority, talked about Pioneering the Surge Towards Climate and Energy Transitions.The conference unfolded over two dynamic days, featuring a packed agenda of insightful presentations and engaging panel discussions. It delved into actionable strategies for decarbonisation, advancements in AgriTech, the evolving carbon market, eco-funds, energy, CCS, built environment and other groundbreaking innovations in climate technology.Notable discussions highlighted the need for farmers to balance carbon stewardship with food production over the next few decades, the importance of consistent government policies to enable businesses to plan and innovate effectively, and the urgency of addressing digital and engineering skill shortages to ensure a successful green energy transition. Industry experts also called for common sustainability metrics to measure corporate efforts fairly, emphasized the value of collaboration over competition to accelerate the green transition, and underscored the need for farmers to access landscape-level data to enhance biodiversity.The exhibition hall featured groundbreaking innovations and solutions in sustainability and climate technology, including carbon capture and storage (CCS) from companies like CGI and Terra CO2 Technology, carbon management and accounting solutions by Greenly and Gaia Carbon Accounting, and emerging climate technologies from innovators such as Nabla Flow and Luna 9. Other exhibitors showcased AI-driven solutions, sustainable energy systems, and innovative carbon reduction technologies, presenting a comprehensive snapshot of the future of climate tech.#CTS24 also hosted interactive side events, including startup acceleration programs and hands-on workshops, providing participants with opportunities for learning, networking, and collaboration. These sessions empowered attendees to adopt transformative technologies and take decisive climate action.Attendee ExperiencesThe event received overwhelming positive feedback:Mark Haley, Co-founder of Cero3, shared, "We’re so proud to have unveiled our sustainable travel planner. The feedback and interest exceeded our expectations."Satyajit Mohanan, Projects and Business Development Coordinator at Cambridge Cleantech, remarked, "It was a pleasure to be part of this event. I met amazing people and look forward to the next edition."Dennis Chacko, Senior Sales Manager at the British Board of Agreement, shared his excitement over a unique sustainable pen: "Once used, you can plant it to grow something new—a powerful reminder of how everyday items can contribute to a greener future."As this successful edition concludes, the organisers are already planning for a bigger, more impactful 4th Edition, with expanded content and greater opportunities to drive meaningful change toward a sustainable future.For further information, please reach out to us at press@valiantandcompany.com. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia SeaPRwire

China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia

SHENZHEN, CHINA, Dec 2, 2024 – (ACN Newswire) – China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 2 December 2024, the Group through a wholly-owned subsidiary of the Company entered into an Exclusive Commercialization Agreement (the “Agreement”) with Atom Therapeutics Co., Ltd (hereinafter referred to as “Atom Therapeutics”, formerly named as “Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.”) of class 1 innovative drug ABP-671 for the treatment of gout and hyperuricemia (the “Product”). In accordance with the Agreement, the Group is entitled to an exclusive commercialization right of the Product in Mainland China, Hong Kong Special Administrative Region and Macao Special Administrative Region. The term of cooperation commences on the effective date of the Agreement and extends for ten years from the date the Product is first approved for market launch in Mainland China (the “Authorization Term”). Upon the expiration of the Authorization Term, it may be automatically renewed for an additional ten years, subject to specific conditions stipulated in the Agreement. ABP-671 is a class 1 innovative chemotherapeutic drug for the treatment of gout and hyperuricemia, currently in Phase 2b/3 clinical trials for gout in China and overseas. The Product reduces renal re-absorption of uric acid by inhibiting Urate Anion Transporter 1 (URAT1). The results of two completed phase 2 clinical trials demonstrated favorable efficacy and safety profiles across multiple dose groups (ranging from 1 mg to 12 mg) of ABP-671. The 2 mg once-daily dosage of the Product was proved to be as effective as, or even better than, benzbromarone or febuxostat (maximum dosage of 80mg). The reduction in uric acid levels was sustained throughout the 24-hour period, with no significant safety concerns identified. This product is anticipated to offer more effective and safer treatment alternatives for patients suffering from gout and hyperuricemia[1]. Multiple patents in regard to substance and use of the ABP-671 have been granted in China. Hyperuricemia is defined as a fasting blood uric acid level exceeding 420μmol/L (7.0 mg/dL) in adults on a normal purine diet on two separate days. The deposition of urate crystals in hyperuricemia patient results in arthritis, medically termed gout. Hyperuricemia and gout can cause acute and chronic inflammatory injury in articular cartilage, bone, kidney and vascular wall, which can lead to multiple organ damage of the heart, brain and kidney, etc. The data presented in the White Paper on Hyperuric Acid and Gout Trends in China (2021) indicates that, the incidence rate of hyperuricemia is 13.3%, with approximately 177 million hyperuricemia patients and the incidence rate of gout is 1.1% in general, with about 14.66 million gout patients in China. Frost & Sullivan indicates that, the number of people with hyperuricemia and gout in China will continue to increase in the future, reaching 240 million and 52.2 million respectively by 2030. Currently, the commonly used uric acid-lowering drugs in clinical practice in China are those which inhibit uric acid synthesis or promote uric acid excretion. Due to certain limitations in the efficacy and safety of the marketed uric acid-lowering drugs, such as causing renal failure, sudden cardiac death or severe liver toxicity. There is still an urgent need for effective and safe uric acid-lowering drugs among gout and hyperuricemia patients in China. ABP-671 is currently with the potential to be the promising and safe product for the treatment of gout and hyperuricemia. Through this collaboration, it fills the blank in the CMS’s product portfolio of the treatment of gout. Gout and hyperuricemia are both rheumatic diseases and chronic metabolic diseases, which are highly consistent with the Group’s strategic layout in the cardio-cerebrovascular/ gastroenterology business and the network resources of marketed products. If approved for marketing in the future, the Product will synergize with the Group’s marketed product Metoject (methotrexate injection) in rheumatology and with Elcitonin (elcatonin injection) in endocrinology and orthopedics, in terms of expert network and market resources. Based on the unmet clinical needs and the expected solid clinical data of the Product, the Group is looking forward to the smooth advancement of the clinical development of ABP-671, allowing patients with relevant indications to benefit from this innovative treatment sooner. About ATOM THERAPEUTICS Atom Therapeutics was founded in March 2012, focused on the research and development of innovative drugs with global commercial value and competitiveness in the metabolic and inflammatory area. Atom Therapeutics’s main core team members come from the United States, with extensive experience in the research and development of innovative drugs. Atom Therapeutics has achieved remarkable development in the past few years. Atom Therapeutics’s core product ABP-671 is under pivotal clinical stage for the treatment of chronic gout. Atom Therapeutics’s another small molecule innovative drug named as ABP-745, used for indications in the field of anti-inflammatory immune indications. The Phase 1 clinical of ABP-745 exhibited outstanding pharmacokinetics and safety. The clinical trial is on the verge of entering Phase 2. For more information about Atom Therapeutics and its pipeline, please visit https://www.atombp.com/. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group. Reference: 1. The results of Phase 2 clinical trials was published and can be found at: https://www.atombp.com/2023/03/01/atom-bioscience-announces-positive-results-of-phase-2a-china-clinical-trial-of-its-urat1-inhibitor-for-chronic-gout/ CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
More
Honda Introduces AI-powered Social Robot, Haru, to University Hospital in Spain JCN Newswire

Honda Introduces AI-powered Social Robot, Haru, to University Hospital in Spain

TOKYO, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - Honda Research Institute Japan Co., Ltd. (HRI-JP), a Honda R&D subsidiary responsible for the research of cutting-edge technologies, has officially introduced its AI-powered social robot named “Haru” at the Virgen del Rocío University Hospital (HUVR) in Seville, Spain, to enhance the well-being of children while in the hospital.At the Annual Gala against Childhood Cancer, held on November 28 local time, at Casino de la Exposicion in Seville, Spain, the HUVR introduced Haru as one of the projects HUVR is implementing to improve the lives of children with cancer, who are in the hospital for long-term treatment.AI-powered social robot, HaruHRI-JP has been developing Haru, an AI-powered social robot, as a “tangible AI system” striving to realize a society where robots coexist as partners of people and to facilitate communications that create connections among people. Haru was designed to be a social robot that makes people smile through expressive communications and forms empathetic relationships with people. As a compact desk-top robot with a total height of 30cm (12 inches), Haru can be placed on a table to engage in communications with people.Haru obtains biometric information of the user, such as facial expressions and voice tones, through its built-in camera and microphones, then analyzes the information obtained to understand the user’s current state, and interacts with each user in accordance with the result of analysis, using empathetic expressions and emotionally supportive responses. Moreover, Haru can also be linked to a wristwatch-type wearable sensor worn by the user and analyze the user’s conditions in greater detail.Furthermore, as a robot, Haru does not have any human attributes such as gender, race or nationality, and is always capable of communicating from a neutral perspective, enabling Haru to effectively facilitate communication beyond generational and cultural differences, especially in group communication.HUVR had been conducting a demonstration experiment using Haru in the pediatric oncology ward of the hospital since 2021 for the purpose of enhancing both the clinical and emotional care of young patients. Since the results of the experiment have confirmed a certain level of positive effects on children with cancer, the official decision was made to advance the project with full-fledged utilization of Haru, introducing 10 units to be used in various situations in the children’s daily lives in the pediatric oncology unit.Key results of the demonstration experiment at the HUVR1. Assisting emotional and cognitive assessmentsHaru has been assisting the hospital’s neuropsychologists in conducting emotional and cognitive assessments. Using AI technology, Haru communicates with children; analyzes their biometric information, such as facial expressions and voice tones, obtained through its built-in cameras and microphones; and assist neuropsychologists in conducting emotional and cognitive assessments.Due to the amount of time the assessment takes, there is a limit to the number of assessments the neuropsychologists can conduct each year: the number had been limited to 510 per year including follow-up consultations until now. With the introduction of Haru, the number of assessments the hospital can conduct each year is expected to increase to as many as 4,500.2. Assisting rehabilitation activitiesHaru has been supporting intellectual and physical rehabilitation programs provided to young patients at the hospital. Haru learns the rehabilitation programs and can guide the children through the process while engaging them in conversation. The demonstration experiment showed that 95% of children were more actively engaged in rehabilitation while receiving guidance from Haru, compared to conventional human guides.3. Serving as a companion in playrooms and hospital roomsYoung patients who undergo long-term hospital stays for treatment spend a lot of time alone in their rooms. By communicating with the children, Haru can offer entertainment and cognitive stimulation, and help to soothe their feeling of loneliness, contributing to the enhancement of emotional care the hospital provides.4. Offering educational supportHaru connects the hospital rooms of the children who have not been able to attend school with the classrooms of their schools online, and facilitates the communication as an intermediary. This provides children at the hospital with opportunity to receive education together with children in the classroom and to interact with each other among children.Comments by the Virgen del Rocío University Hospital in Seville (HUVR)“We have been conducting joint research with HRI-JP for several years now, and gained wonderful results. We have identified that Haru holds great potential in bringing happiness to children. Typically, technologies used in hospitals focus on medical treatments or physical well-being. However, Haru has positive psychological effect of lightening the mood of our young patients and also contributes to the well-being of the hospital as a whole. The support that Haru provides, enabling children under hospital care to feel more happiness and connection with others, is unique only to Haru and offers valuable benefits not found in traditional medical care. We believe that Haru is a groundbreaking presence that creates an environment where young patients can enjoy their time here at our hospital.”Comments by Satoshi Shigemi, Honda Research Institute Japan Co., Ltd. (HRI-JP)“Based on the founding spirit of Honda, ‘using our technology to help people’ and ‘understanding people is the very essence of Honda monozukuri (art of making things),’ Honda Research Institute has been conducting research into cutting-edge technologies which have the potential to enhance positive psychological effects of people and the overall well-being of society. We are delighted by the result of our joint research with Virgen del Rocío University Hospital that shows Haru has been able to be a companion to the children at the hospital, lifting up their spirits, and bringing smiles to their faces. Moving forward, we will continue our efforts to further advance Haru as a robot which can co-exist with people 24/7 and be more helpful to young patients as well as all hospital staff to contribute to the well-being of the hospital a whole.”About Honda Research Institute (HRI)HRI was established in 2003 as a research operation which will go beyond the framework of the traditional business domain of the Honda Group and take on challenges to address issues facing humanity. Each of three HRI operations, located in Japan, the United States, and Germany, is engaged in “frontier research” with a focus on next-generation AI, including the exploration of new technologies such as quantum technology. By using Pasteur's Quadrant approach to research, which calls for the simultaneous pursuit of principles, or science, and real-world applications, HRI is striving to quickly give shape to new technologies and ideas, and create new value that can be useful to society. The research outcomes generated by HRI will lead toward the development of future Honda technologies in a wide range of technology fields, including but not limited to the areas of safety, the environment and next-generation mobility.Honda Research Institute Japan Co., Ltd. (HRI-JP), a Honda R&D subsidiary responsible for the research of cutting-edge technologies, has officially introduced its AI-powered social robot named “Haru” at the Virgen del Rocío University Hospital (HUVR) in Seville, Spain, to enhance the well-being of children while in the hospital.At the Annual Gala against Childhood Cancer, held on November 28 local time, at Casino de la Exposicion in Seville, Spain, the HUVR introduced Haru as one of the projects HUVR is implementing to improve the lives of children with cancer, who are in the hospital for long-term treatment.AI-powered social robot, HaruHRI-JP has been developing Haru, an AI-powered social robot, as a “tangible AI system” striving to realize a society where robots coexist as partners of people and to facilitate communications that create connections among people. Haru was designed to be a social robot that makes people smile through expressive communications and forms empathetic relationships with people. As a compact desk-top robot with a total height of 30cm (12 inches), Haru can be placed on a table to engage in communications with people.Haru obtains biometric information of the user, such as facial expressions and voice tones, through its built-in camera and microphones, then analyzes the information obtained to understand the user’s current state, and interacts with each user in accordance with the result of analysis, using empathetic expressions and emotionally supportive responses. Moreover, Haru can also be linked to a wristwatch-type wearable sensor worn by the user and analyze the user’s conditions in greater detail.Furthermore, as a robot, Haru does not have any human attributes such as gender, race or nationality, and is always capable of communicating from a neutral perspective, enabling Haru to effectively facilitate communication beyond generational and cultural differences, especially in group communication.HUVR had been conducting a demonstration experiment using Haru in the pediatric oncology ward of the hospital since 2021 for the purpose of enhancing both the clinical and emotional care of young patients. Since the results of the experiment have confirmed a certain level of positive effects on children with cancer, the official decision was made to advance the project with full-fledged utilization of Haru, introducing 10 units to be used in various situations in the children’s daily lives in the pediatric oncology unit.Key results of the demonstration experiment at the HUVR1. Assisting emotional and cognitive assessmentsHaru has been assisting the hospital’s neuropsychologists in conducting emotional and cognitive assessments. Using AI technology, Haru communicates with children; analyzes their biometric information, such as facial expressions and voice tones, obtained through its built-in cameras and microphones; and assist neuropsychologists in conducting emotional and cognitive assessments.Due to the amount of time the assessment takes, there is a limit to the number of assessments the neuropsychologists can conduct each year: the number had been limited to 510 per year including follow-up consultations until now. With the introduction of Haru, the number of assessments the hospital can conduct each year is expected to increase to as many as 4,500.2. Assisting rehabilitation activitiesHaru has been supporting intellectual and physical rehabilitation programs provided to young patients at the hospital. Haru learns the rehabilitation programs and can guide the children through the process while engaging them in conversation. The demonstration experiment showed that 95% of children were more actively engaged in rehabilitation while receiving guidance from Haru, compared to conventional human guides.3. Serving as a companion in playrooms and hospital roomsYoung patients who undergo long-term hospital stays for treatment spend a lot of time alone in their rooms. By communicating with the children, Haru can offer entertainment and cognitive stimulation, and help to soothe their feeling of loneliness, contributing to the enhancement of emotional care the hospital provides.4. Offering educational supportHaru connects the hospital rooms of the children who have not been able to attend school with the classrooms of their schools online, and facilitates the communication as an intermediary. This provides children at the hospital with opportunity to receive education together with children in the classroom and to interact with each other among children.Comments by the Virgen del Rocío University Hospital in Seville (HUVR)“We have been conducting joint research with HRI-JP for several years now, and gained wonderful results. We have identified that Haru holds great potential in bringing happiness to children. Typically, technologies used in hospitals focus on medical treatments or physical well-being. However, Haru has positive psychological effect of lightening the mood of our young patients and also contributes to the well-being of the hospital as a whole. The support that Haru provides, enabling children under hospital care to feel more happiness and connection with others, is unique only to Haru and offers valuable benefits not found in traditional medical care. We believe that Haru is a groundbreaking presence that creates an environment where young patients can enjoy their time here at our hospital.”Comments by Satoshi Shigemi, Honda Research Institute Japan Co., Ltd. (HRI-JP)“Based on the founding spirit of Honda, ‘using our technology to help people’ and ‘understanding people is the very essence of Honda monozukuri (art of making things),’ Honda Research Institute has been conducting research into cutting-edge technologies which have the potential to enhance positive psychological effects of people and the overall well-being of society. We are delighted by the result of our joint research with Virgen del Rocío University Hospital that shows Haru has been able to be a companion to the children at the hospital, lifting up their spirits, and bringing smiles to their faces. Moving forward, we will continue our efforts to further advance Haru as a robot which can co-exist with people 24/7 and be more helpful to young patients as well as all hospital staff to contribute to the well-being of the hospital a whole.”About Honda Research Institute (HRI)HRI was established in 2003 as a research operation which will go beyond the framework of the traditional business domain of the Honda Group and take on challenges to address issues facing humanity. Each of three HRI operations, located in Japan, the United States, and Germany, is engaged in “frontier research” with a focus on next-generation AI, including the exploration of new technologies such as quantum technology. By using Pasteur's Quadrant approach to research, which calls for the simultaneous pursuit of principles, or science, and real-world applications, HRI is striving to quickly give shape to new technologies and ideas, and create new value that can be useful to society. The research outcomes generated by HRI will lead toward the development of future Honda technologies in a wide range of technology fields, including but not limited to the areas of safety, the environment and next-generation mobility.HRI-JP has been developing Haru, an AI-powered social robot, as a “tangible AI system” striving to realize a society where robots coexist as partners of people and to facilitate communications that create connections among people. Haru was designed to be a social robot that makes people smile through expressive communications and forms empathetic relationships with people. As a compact desk-top robot with a total height of 30cm (12 inches), Haru can be placed on a table to engage in communications with people.Haru obtains biometric information of the user, such as facial expressions and voice tones, through its built-in camera and microphones, then analyzes the information obtained to understand the user’s current state, and interacts with each user in accordance with the result of analysis, using empathetic expressions and emotionally supportive responses. Moreover, Haru can also be linked to a wristwatch-type wearable sensor worn by the user and analyze the user’s conditions in greater detail.Furthermore, as a robot, Haru does not have any human attributes such as gender, race or nationality, and is always capable of communicating from a neutral perspective, enabling Haru to effectively facilitate communication beyond generational and cultural differences, especially in group communication.HUVR had been conducting a demonstration experiment using Haru in the pediatric oncology ward of the hospital since 2021 for the purpose of enhancing both the clinical and emotional care of young patients. Since the results of the experiment have confirmed a certain level of positive effects on children with cancer, the official decision was made to advance the project with full-fledged utilization of Haru, introducing 10 units to be used in various situations in the children’s daily lives in the pediatric oncology unit.Key results of the demonstration experiment at the HUVR1. Assisting emotional and cognitive assessmentsHaru has been assisting the hospital’s neuropsychologists in conducting emotional and cognitive assessments. Using AI technology, Haru communicates with children; analyzes their biometric information, such as facial expressions and voice tones, obtained through its built-in cameras and microphones; and assist neuropsychologists in conducting emotional and cognitive assessments.Due to the amount of time the assessment takes, there is a limit to the number of assessments the neuropsychologists can conduct each year: the number had been limited to 510 per year including follow-up consultations until now. With the introduction of Haru, the number of assessments the hospital can conduct each year is expected to increase to as many as 4,500.2. Assisting rehabilitation activitiesHaru has been supporting intellectual and physical rehabilitation programs provided to young patients at the hospital. Haru learns the rehabilitation programs and can guide the children through the process while engaging them in conversation. The demonstration experiment showed that 95% of children were more actively engaged in rehabilitation while receiving guidance from Haru, compared to conventional human guides.3. Serving as a companion in playrooms and hospital roomsYoung patients who undergo long-term hospital stays for treatment spend a lot of time alone in their rooms. By communicating with the children, Haru can offer entertainment and cognitive stimulation, and help to soothe their feeling of loneliness, contributing to the enhancement of emotional care the hospital provides.4. Offering educational supportHaru connects the hospital rooms of the children who have not been able to attend school with the classrooms of their schools online, and facilitates the communication as an intermediary. This provides children at the hospital with opportunity to receive education together with children in the classroom and to interact with each other among children.Comments by the Virgen del Rocío University Hospital in Seville (HUVR)“We have been conducting joint research with HRI-JP for several years now, and gained wonderful results. We have identified that Haru holds great potential in bringing happiness to children. Typically, technologies used in hospitals focus on medical treatments or physical well-being. However, Haru has positive psychological effect of lightening the mood of our young patients and also contributes to the well-being of the hospital as a whole. The support that Haru provides, enabling children under hospital care to feel more happiness and connection with others, is unique only to Haru and offers valuable benefits not found in traditional medical care. We believe that Haru is a groundbreaking presence that creates an environment where young patients can enjoy their time here at our hospital.”Comments by Satoshi Shigemi, Honda Research Institute Japan Co., Ltd. (HRI-JP)“Based on the founding spirit of Honda, ‘using our technology to help people’ and ‘understanding people is the very essence of Honda monozukuri (art of making things),’ Honda Research Institute has been conducting research into cutting-edge technologies which have the potential to enhance positive psychological effects of people and the overall well-being of society. We are delighted by the result of our joint research with Virgen del Rocío University Hospital that shows Haru has been able to be a companion to the children at the hospital, lifting up their spirits, and bringing smiles to their faces. Moving forward, we will continue our efforts to further advance Haru as a robot which can co-exist with people 24/7 and be more helpful to young patients as well as all hospital staff to contribute to the well-being of the hospital a whole.”About Honda Research Institute (HRI)HRI was established in 2003 as a research operation which will go beyond the framework of the traditional business domain of the Honda Group and take on challenges to address issues facing humanity. Each of three HRI operations, located in Japan, the United States, and Germany, is engaged in “frontier research” with a focus on next-generation AI, including the exploration of new technologies such as quantum technology. By using Pasteur's Quadrant approach to research, which calls for the simultaneous pursuit of principles, or science, and real-world applications, HRI is striving to quickly give shape to new technologies and ideas, and create new value that can be useful to society. The research outcomes generated by HRI will lead toward the development of future Honda technologies in a wide range of technology fields, including but not limited to the areas of safety, the environment and next-generation mobility. Copyright 2024 JCN Newswire via SeaPRwire.com.
More
DENSO to Exhibit at “Automechanika Dubai 2024” JCN Newswire

DENSO to Exhibit at “Automechanika Dubai 2024”

KARIYA, JAPAN, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - DENSO Sales Middle East & North Africa (DSMN), a group company of DENSO Corporation, will participate in “Automechanika Dubai 2024,” held at the Dubai World Trade Centre from December 10 to 12, 2024.Established in 2010 in Dubai, DSMN serves the Middle East and North Africa regions by offering aftermarket products and services. In these regions, motorization is advancing, and vehicles tend to have longer operational lifespans. DSMN strives to provide customers and users with peace of mind and trust through high-quality products and services, contributing to the realization of a sustainable mobility society.Automechanika Dubai is the largest automotive aftermarket trade show in the Middle East and Africa. This year, over 2,200 exhibitors are expected to participate. Many visitors are businesses seeking to establish partnerships with exhibitors, and attendance is anticipated to exceed last year’s 52,469 visitors from 161 countries. The event offers an excellent opportunity to expand business possibilities, not only in the Middle East and Africa but also in regions such as West Asia and Central Asia.Through this exhibition, DSMN aims to showcase aftermarket solutions and explore opportunities for advanced technology-based products and services. Additionally, DSMN will deepen interactions with customers and partner companies, identifying new needs and pursuing tailored solutions to address regional challenges.Booth ImageDSMN Website: https://denso.ae/Please see here for more details on DSMN’s booth: https://denso.ae/events/join-us-at-automechanika-dubai-2024-celebrating-75-years-of-innovation Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Fujitsu expands global strategic collaboration agreement with AWS to promote customer digital transformation across industries JCN Newswire

Fujitsu expands global strategic collaboration agreement with AWS to promote customer digital transformation across industries

KAWASAKI, Japan, Dec 2, 2024 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has signed a three-year global strategic collaboration agreement (SCA) with Amazon Web Services (AWS) (1). This collaboration, officially concluded on November 29, expands the existing agreements in the mobility, finance, and retail sectors to a broader range of industries .Through this collaboration, Fujitsu will combine its expertise in systems integration and its Fujitsu Uvance offering to solve societal issues with AWS’s cloud services and cloud-native architecture to accelerate customers' digital transformation (DX) and address business challenges.Additionally, with AWS’s skills training, Fujitsu aims to strengthen its delivery system by increasing the number of Fujitsu engineers who have AWS certifications from approximately 7,000 to 12,000 over the next three years and double the number of customer deals to over 800 compared to the past 3-year SCA period.BackgroundWith the target year of 2030 for achieving the United Nations Sustainable Development Goals (SDGs) approaching, Fujitsu is promoting Fujitsu Uvance, its business model that aims to increase business growth and solve societal issues.Fujitsu Uvance leverages Fujitsu's extensive technology and industry expertise to seamlessly integrate fragmented processes and data, with the aim of creating new solutions and insights for customers. To achieve this, it is crucial to move away from legacy systems and strategically utilize cloud computing with partners. By expanding strategic collaboration with AWS, the world’s most comprehensive and broadly adopted cloud, and creating a combined solution that address customers business challenges and opportunities, Fujitsu will drive digital transformation across industries.Overview of the Initiatives1. Strengthening Fujitsu’s AWS cloud migration support servicesIn addition to having customers core systems run on their mainframes and UNIX servers, which was a strategic target of the legacy modernization collaboration announced in March 2024, the two companies will strengthen migration support services for broader on-premise systems to move onto AWS. Fujitsu will provide a comprehensive set of cloud-native system integration and operation support services through Fujitsu Cloud Transformation Service and Fujitsu Cloud Managed Service (2), with technical support from AWS.2. Enhancing added value through the service integration of Fujitsu Uvance offerings and AWSFujitsu aims to enhance added value and expand the global provision of Fujitsu Uvance offerings focusing on the two pillars of Trusted Society for a prosperous and sustainable society and Digital Shifts to support customers' data-driven strategies. As part of this effort, Fujitsu has started linking the Digital Shifts offering with its Fujitsu Kozuchi AI service and Amazon Bedrock, AWS's generative AI service. For example, Fujitsu Data Intelligence Premium, an operation platform that utilizes data and AI, analyzes production line data from factories, uses AI to detect risk signs and propose countermeasures based on past cases, and converts past inspection reports into reusable structured data to visualize and share accumulated know-how in facility maintenance work within organizations. By combining business knowledge cultivated over many years with the latest technologies such as generative AI, Fujitsu will help customers improve the efficiency and the uptime of their production processes. Demonstrations of these use cases will be showcased at the Fujitsu booth during AWS re:Invent 2024 starting today in Las Vegas, US.(3)3. Reinforcing Fujitsu’s system development and delivery capabilities by increasing the number of AWS certification holdersFujitsu aims to increase the number of Fujitsu engineers who hold AWS certifications from approximately 7,000 to 12,000 over the next three years, through AWS skills training. By increasing the number of professionals who have a deep understanding of AWS cloud services, Fujitsu will accelerate the delivery of systems that realize customers' DX, doubling the number of customer deals to over 800 compared to past 3-year SCA period.Role of Fujitsu and AWS- FujitsuLeverage its customer base and system development expertise in various industries to reach enterprise and mid-market customers.Through offerings such as legacy system modernization, cloud migration and operational support, and Fujitsu Uvance, Fujitsu will support customers' DX.- AWSAWS will strengthen its technical support for Fujitsu with its solution architects and provide advisories on the use of latest AWS services such as generative AI and cloud-native architectures for diverse use cases. AWS will also provide development environments to review latest AWS services, while also offering funds for joint sales and marketing, and AWS training and certifications for Fujitsu engineers.Yoshinami Takahashi, Vice President and COO for Uvance, Fujitsu Limited comments:“We are pleased to have concluded this global strategic collaboration with AWS. By extending our strategic collaboration to a broader range of industries, we will contribute to the digital transformation of customers across industries through legacy modernization, cloud lift and shift, and the utilization of technology and data offerings from Fujitsu Uvance together with AWS."Jaime Vallés, Vice President, Asia Pacific and Japan, Amazon Web Services comments:"Since 2012, AWS and Fujitsu have supported the digital transformation of customers in the mobility, finance, and retail sectors in Japan and worldwide. Today, we are delighted to expand our strategic collaboration with Fujitsu. Together we will broaden our Digital Transformation Experience to enable a wider range of industries and leverage our shared culture of innovation to jointly address some of the world’s biggest challenges."(1) Amazon Web Services: Headquartered in Seattle, Washington, USA, CEO Matt Garman. The collaboration was concluded with Amazon Web Services Japan GK (Head Office: Shinagawa-ku, Tokyo; President: Akihiko Shirahata).(2) Fujitsu Cloud Transformation Service and Fujitsu Cloud Managed Service: Based on Fujitsu's system design, construction, and operation know-how cultivated mainly in the enterprise domain, these services realize standardization and automation of architecture patterns, ensuring high quality while achieving cost-optimized and rapid delivery. Fujitsu adopts the "AWS Well-Architected Framework" in its delivery services, which is optimized for AWS, and has obtained the "AWS Managed Service Provider (MSP)" certification, proving the soundness and high technical capability of its AWS business.(3) AWS re:Invent: AWS’s annual global conference that starts from December 2, 2024 in Las Vegas. For more information on AWS re:Invent, please visit: https://reinvent.awsevents.com/About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2024 JCN Newswire via SeaPRwire.com.
More
康哲藥業獲得治療痛風及高尿酸血症的1類新藥獨家商業化權利 ACN Newswire

康哲藥業獲得治療痛風及高尿酸血症的1類新藥獨家商業化權利

深圳, 2024年12月2日 - (亞太商訊 via SeaPRwire.com) - 康哲藥業控股有限公司(以下簡稱「康哲藥業」)欣然宣佈,於2024年12月2日,通過其全資附屬公司與杭州新元素藥業有限公司(以下稱「新元素藥業」,曾用名「江蘇新元素醫藥科技有限公司」)就治療痛風及高尿酸血症的1類新藥ABP-671(「產品」)簽訂獨家商業化協議(「協議」)。根據協議,康哲藥業獲得產品在中國大陸、香港特別行政區及澳門特別行政區的獨家商業化權利。合作期限開始於協議生效之日,自產品首次在中國大陸獲批上市起擁有十年的授權期限(「授權期限」)。授權期限屆滿後,根據協議約定的特定條件,授權期限可自動續期十年。ABP-671是用於治療痛風及高尿酸血症的化藥1類創新藥,目前正分別在中國和境外開展關於痛風的2b/3期臨床試驗,產品通過抑制尿酸鹽轉運蛋白1(URAT1),降低腎臟對尿酸的重吸收。在已經完成的兩項2期臨床試驗結果顯示,ABP-671多個劑量組(1mg至12mg)表現出良好的藥效和安全性。該產品2mg每天單次給藥,其藥效可能相當於或優於苯溴馬隆和非布司他最高劑量80mg的藥效。尿酸下降可維持全天候24小時,沒有出現嚴重的安全性問題。產品有望為痛風及高尿酸血症患者帶來療效更優、安全性更高的治療選擇[1]。與ABP-671相關的化合物和用途方面的多個專利已在中國獲得授權。高尿酸血症是指成人在正常嘌呤飲食情況下,非同日2次空腹血尿酸水平超過420μmol/L (7.0mg/dL)。高尿酸血症患者出現尿酸鹽晶體沉積,導致痛風性關節炎,稱為痛風。高尿酸血症及痛風可引起關節軟骨、骨質、腎臟以及血管壁等急慢性炎症損傷,導致心、腦、腎等多器官損害。《2021中國高尿酸及痛風趨勢白皮書》數據顯示,我國高尿酸血症的總體的患病率為13.3%,高尿酸血症患病人數約1.77億人,痛風總體發病率為1.1%,患病人數約為1,466萬。據弗若斯特沙利文分析,未來中國高尿酸血症和痛風患病人數會持續增加,將在2030年分別達到2.4億人、5,220萬人。目前我國臨床上常用的降尿酸藥物主要包括抑制尿酸合成和促進尿酸排泄兩類,由於已上市降尿酸藥物在療效和安全性上仍存在一定的局限性,如導致腎衰竭、心臟猝死或嚴重肝臟毒性等。中國痛風及高尿酸血症患者對高效安全的降尿酸藥物仍然有迫切的需求。ABP-671是當前痛風及高尿酸血症治療中潛在療效優、安全性好的產品。通過本次合作引進,填補了康哲藥業痛風治療產品的空白。痛風及高尿酸血症既屬於風濕疾病又屬於慢性代謝性疾病,與康哲藥業心腦血管/消化業務的戰略佈局,以及在售品種的網絡資源高度契合。ABP-671如未來獲批上市,在風濕免疫科可與在售產品美泰彤(甲氨蝶呤注射液),在內分泌科和骨科可與益蓋寧(依降鈣素注射液)在專家網絡與市場資源方面協同。基於未滿足的臨床需求和產品預期扎實的臨床數據,期待ABP-671的臨床開發工作順利推進,使相關適應症患者儘快從創新療法中獲益。關於新元素藥業新元素藥業創辦於2012年3月,專注於代謝和炎症領域疾病中具有全球商業價值和全球競爭力的創新藥的研發。新元素藥業主要核心團隊人員來自美國,具有廣泛的創新藥物的研發經驗,過去幾年新元素藥業取得了顯著的發展成果。其核心產品ABP-671正處於後期臨床研發階段,用於治療慢性痛風;另一個小分子創新藥物ABP-745用於抗炎自免領域適應症,已完成1期臨床,表現出良好的PK和安全性,即將進入2期臨床。有關新元素藥業及其產品的更多信息,請訪問其官方網站:https://www.atombp.com/。關於康哲藥業康哲藥業是一家鏈接醫藥創新與商業化,把控產品全生命週期管理的開放式平臺型企業,致力於提供有競爭力的產品和服務,滿足尚未滿足的醫療需求。康哲藥業專注於全球首創(FIC)及同類最優(BIC)的創新產品,並高效推進創新產品臨床研究開發和商業化進程,賦能科研成果向診療實踐的持續轉化,造福患者。康哲藥業聚焦專科領域,擁有被驗證的商業化能力,廣泛的渠道覆蓋和多疾病領域專家資源,核心在售產品已獲領先的學術與市場地位。康哲藥業圍繞優勢專科領域不斷縱深發展,以鞏固心腦血管/消化業務競爭力,並將皮膚醫美、眼科業務獨立運營,培育專科小領域的大龍頭,提升專科規模效率。同時業務版圖拓展至東南亞市場,著力成為全球藥企進軍東南亞市場的「橋頭堡」,助力康哲藥業高質量持續健康發展。參考文獻:1.產品2期臨床試驗結果已發佈,詳情如下:https://www.atombp.com/2023/03/01/atom-bioscience-announces-positive-results-of-phase-2a-china-clinical-trial-of-its-urat1-inhibitor-for-chronic-gout/康哲藥業免責與前瞻性聲明本新聞無意向您做任何產品的推廣,非廣告用途。本新聞不對任何藥品和醫療器械和/或適應症作推薦。若您想瞭解具體疾病診療信息,請遵從醫生或其他醫療衛生專業人士的意見或指導。醫療衛生專業人士作出的任何與治療有關的決定應根據患者的具體情況並遵照藥品說明書。由康哲藥業編制的此新聞不構成購買或認購任何證券的任何要約或邀請,不形成任何合約或任何其他約束性承諾的依據或加以依賴。本新聞由康哲藥業根據其認為可靠之資料及數據編制,但康哲藥業並無進行任何說明或保證、明述或暗示,或其他表述,對本新聞內容的真實性、準確性、完整性、公平性及合理性不應加以依賴。本新聞中討論的若干事宜可能包含涉及康哲藥業的市場機會及業務前景的陳述,該等陳述分別或統稱為前瞻性聲明。該等前瞻性聲明並非對未來表現的保證,存在已知及未知的風險、不明朗性及難以預知的假設。康哲藥業並不採納本新聞包含的第三方所做的任何前瞻性聲明及預測,康哲藥業對該等第三方聲明及預測不承擔責任。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More